0001209191-19-020163.txt : 20190319 0001209191-19-020163.hdr.sgml : 20190319 20190319082917 ACCESSION NUMBER: 0001209191-19-020163 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190317 FILED AS OF DATE: 20190319 DATE AS OF CHANGE: 20190319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Grady Brendan P. CENTRAL INDEX KEY: 0001726533 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16174 FILM NUMBER: 19690253 MAIL ADDRESS: STREET 1: 5 BASEL STREET, PO BOX 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 4951033 FORMER NAME: FORMER CONFORMED NAME: O'Grady Brendan DATE OF NAME CHANGE: 20171227 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD CENTRAL INDEX KEY: 0000818686 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 BAZEL ST STREET 2: P O B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 BUSINESS PHONE: 9729267267 MAIL ADDRESS: STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED STREET 2: 5 BAZEL ST PO B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-17 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001726533 O'Grady Brendan P. C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 5 BASEL STREET PETACH TIKVA L3 4951033 ISRAEL 0 1 0 0 EVP, North America Commercial Ordinary Shares 2019-03-17 4 M 0 1179 A 2567.486 D Ordinary Shares 2019-03-18 4 S 0 1179 16.6251 D 1388.486 D Restricted Share Units 2019-03-17 4 M 0 1179 0.00 D Ordinary Shares 1179 1179 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.5800 to $16.6800, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Restricted share units were granted on March 17, 2016, with 1,179 vesting on each of March 17, 2018, March 17, 2019 and March 17, 2020. /s/ Dov Bergwerk, as attorney-in-fact for Brendan P. O'Grady 2019-03-19